Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus

Journal of Molecular Medicine

Volumn 76, Issue 1, 1998, Pages 21-31

  Ishii, Hidehiro ^a   Koya, Daisuke ^a   King, George L ^a,b,c,d  

^a JOSLIN DIABETES CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Diacylglycerol; Protein kinase C; Specific inhibitor for protein kinase C isoforms; Vascular complications; Vitamin E

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; CONTRACTILE PROTEIN; DIACYLGLYCEROL; PHOSPHOLIPASE A2; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

BASEMENT MEMBRANE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; ENZYME ACTIVATION; HYPERGLYCEMIA; KIDNEY BLOOD FLOW; RETINA BLOOD FLOW; REVIEW; VASCULAR DISEASE;

EID: 0031883161     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s109-1998-8101-y     Document Type: Review

References (132)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
2. Greene D, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606
3. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321
4. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813
5. King GL, Kunisaki M, Nishi N, Inoguchi T, Shiba T, Xia P (1996) Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 45 [Suppl 3]:S105-108
6. Nishizuka Y (1992) Intracellular Signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614
7. Nakanishi H, Brewer KA, Exton JH (1993) Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 266:13-16
8. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AM (1990) Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85: 1991-1998
9. Rasmussen H, Forder J, Kojima I, Scriabine A (1984) TPA-induced contraction of isolated rabbit vascular smooth muscle. Biodhem Biophys Res Commun 122:776-784
10. Kariya K, Kawahara Y, Tsuda T, FukuzakiH, Takai Y (1987) Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis 63:251-255
11. Huhtala P, Chow LT, Tryggvason K (1990) Structure of the human type IV collagen gene. J Biol Chem 265: 11077-11082
12. Hachiya HL, Takayama S, White MF, King GL (1987) Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol esters. J Biol Chem 262: 6417-6424
13. Presta M, Maier JAM, Ragnotti G (1989) The mitogenic signaling pathway but not plasminogen activator inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Cell Biol 109:1877-1884
14. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL (1992) Preferential elevation of protein kinase C isoform bII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89:11059-11063
15. Shiba T, Inoguchi T, Sportsman JR, Heath W, Bursell S, King GL (1993) Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265: E783-E793
16. Craven PA, DeRubertis FR (1989) Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83:1667-1675
17. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731
18. Considine RV, Nyce MR, Allen LE, Morales LM, Triester S, Serrano J, Colberg J, Lanza-Jacoby S, Caro JF. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J. Clin. Invest. 1995 95:2938-2944
19. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129
20. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI (1991) High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-577
21. Studer RK, Craven PA, DeRubertis FR (1993) Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 42:118-126
22. Inoguchi T, Pu X, Kunisaki M, Higashi S, Feener EP, King GL (1994) Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369-379
23. Holub BJ, Kuksis A (1986) Metabolism of molecular species of diacylglycerol phospholipids. Adv Lipid Res 16:1-125
24. Dunlop ME, Larkins RG (1985) Pancreatic islets synthesize phospholipids de novo from glucose via acyl-dihydroxyacetone phosphate. Biochem Biophys Res Commun 132: 467-473
25. Brindley DN, Sturton RG (1982) Phosphatidate metabolism and its relation to triacylglycerol biosynthesis. In: Hawthorne JN, Ansel GB (eds) Phospholipids. Elsevier, New York, pp 179-207
26. 26a. Go M, Sekiguchi K, Nomura H, Kikkawa N, Nishizuka Y (1987) Further studies on the specificity of diacylglycerol for protein kinase C activation. Biochem Biophys Res Commun 144:598-605
27. 26b. Taher MM, Garcia JG, Natarajan V (1993) Hydroperoxide-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch. Biochem-Biophys 303:260-266
28. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J (1996) Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension 28:159-68
29. Kunisaki M, Bursell S-E, Umeda F, Nawata H, King GL (1994) Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377
30. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y (1994) Translocation of protein kinase a and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37:838-841
31. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334:661-665
32. Nishizuka Y (1989) The family of protein kinase C for signal transduction. JAMA 262:1826-1833
33. Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH (1994) Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35: 2968-2975
34. Bursell S-E, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA (1996) Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886-897
35. Small KW, Stefansson E, Hatchell D (1987) Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci 28:672-675
36. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell S-E (1994) Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35:981-990
37. Miyamoto K, Ogura Y, Nishiwaki H, Matsuda N, Honda Y, Kato S, Ishida H, Seino Y (1996) Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. Invest Ophthalmol Vis Sci 37:898-905
38. Takagi C, Bursell S-E, Lin Y-W, Takagi H, Duh E, Jiang Z, Clermont AC, King GL (1996) Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 37:2504-2518
39. Ditzel J, Schwartz M (1967) Abnormally increased glomerular filtration rates in short-term insulin treated diabetic subjects. Diabetes 16:264-267
40. Chiristiansen JS, Gammelgaard J, Frandsen M, Parving HH (1981) Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetes. Diabetologia 20:451-456
41. Hostetter TH, Troy JL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415
42. Viberti GC (1979) Early functional and morphological changes in diabetic nephropathy. Clin Nephrol 12:47-53
43. Schambelan M, Blake S (1985) Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75:404-412
44. Craven PA, Caines MA, DeRubertis FR (1987) Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes. Metabolism 36:95-103
45. Williams B, Schrier RW (1993) Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896
46. 2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429-435
47. Perico N, Benigni A, Gabanelli M, Piccinelli A, Ròg M, Riva CD, Remuzzi G (1992) Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 41:533-538
48. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 268:1960-1964
49. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278
50. Bank N, Aynedjian HS (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 43:1306-1312
51. Tolins JP, Shultz PJ, Raij L, Brown DM, Mauer SM (1993) Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 265:F886-F895
52. Komers R, AllenTJ, Cooper ME (1994) Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43:1190-1197
53. Sharma K, Danoff TM, DePiero A, Ziyadeh FN (1995) Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 207:80-88
54. Wang Y-X, Brooks DP, Edwards RM (1993) Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am J Physiol 264:R952-R956
55. Craven PA, Studer RK, DeRubertis FR (1994) Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 93:311-320
56. Craven PA, Studer RK, DeRubertis FR (1995) Impaired nitric oxide release by glomeruli from diabetic rats. Metabolism 44:695-698
57. Yagihashi N, Nishida N, Seo HG, Taniguchi N, Yagihashi S (1996) Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats. Diabetologia 39:793-799
58. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, Schmidt HHHW (1992) Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89:11993-11997
59. Ito S, Ren YL (1993) Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 92:1093-1098
60. Kamata K, Miyata N, Kasuya Y (1989) Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in native and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 249:890-894
61. Mayhan WG (1989) Impairment of endothelium-dependent dilatation cerebral arterioles during diabetes mellitus. Am J Physiol 256:H621-H625
62. 2. Am J Physiol 257:H1327-H1333
63. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW (1992) Impaired endothelium-dependent and independent vusodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diahetologia 35:771-776
64. Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643-1648
65. Ohara Y, Sayegh HS, Yamin JJ, Harrison DG (1995) Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 25:415-420
66. Hirata K, Kuroda R, Sakoda T, Katuyama M, Inoue N, Suematsu, Kawashima S, Yokoyama M (1995) Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25:180-185
67. Aiello LP, Robinson GS, Lin Y-W, Nishio Y, King GL (1994) Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci USA 91: 6231-6235
68. Kunisaki M, Jirousek MR, Feener EP, King GL (1995) Normalization of glucose-induced gene expression, caldesmon. both in vitro and in vivo by an isoform-selective protein kinase C (PKC) inhibitor. Diabetes 44 |Suppl 1|:59A
69. Bryan J, Imai M, Lee R, Moore P, Cook RG, Lin W-G (1989) Cloning and expression of a smooth muscle caldesmon. J Biol Chem 264:13873-13879
70. Watson MH, Kuhn AE, Novy RE, Lin JJ-C, Mak AS (1990) Caldesmon-binding sites on tropomyosin. J Biol Chem 265: 18860-18866
71. Hemric ME, Chalovich JM (1990) Characterization of caldesmon binding to myosin. J Biol Chem 265:19672-19678
72. Williamson JR, Kilo C (1984) Extracellular matrix changes in diabetes mellitus. In: Scarpelli DG, Migahi G (eds) Comparative pathobiology of major age-related diseases. Liss, New York, pp 269-288
73. Scheinman JL, Fish AJ, Matas AJ, Michael AF (1978) The immunohistopathology of glomerular antigens. II. The glomerular basement membrane, actomyosin, and fibroblast surface antigens in normal, diseased and transplanted human kidneys. Am J Pathol 90:71-88
74. Bruneval P, Foidart JM, Nochy D, Camilleri JP, Bariety J (1985) Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol 16:477-484
75. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H (1992) ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527
76. Ayo SH, Radnik RA, Garoni J, Glass II WF, Kreisberg JI (1990) High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339-1348
77. Ayo SH, Radnik RA, Glass II WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI (1991) Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191
78. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y (1991) Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200
79. Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM, Mario UD (1994) Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43: 478-490
80. 1 (IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267:F632-F638
81. Cagliero E, Roth T, Roy S, Lorenzi M (1991) Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured endothelial cells. Diabetes 40:102-110
82. Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M (1991) Expression of genes related the extracellular matrix in human endothelial cells. J Biol Chem 266:14244-14250
83. Spiro MJ, Crowley TJ (1993) Increased rat myocardial type VI collagen in diabetes mellitus and hypertension. Diabetologia 36:93-98
84. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE (1989) Transforming growth factor β. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167
85. Suzuki S, Ebihara I, Tomino Y, Koide H (1993) Transcriptional activation of matrix genes by transforming growth factor beta 1 in mesangial cells. Exp Nephrol 1:229-237
86. Nakamura T, Miller D, Ruoslahti E, Border WA (1992) Production of extracellular matrix by glomerular epithelial cells in regulated by transforming growth factor-β1. Kidney Int 41: 1213-1221
87. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA (1993) Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818
88. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H (1993) mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456
89. Sharma K, Ziyadeh FN (1994) Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101
90. Pankewycz OG, Guan J-X, Bolton WK, Gomez A, Benedict JF (1994) Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 46:748-758
91. Shankland SJ, Scholey JW (1994) Expression of transforming growth factor-β1 during diabetic hypertrophy. Kidney Int 46:430-442
92. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN (1992) High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656
93. Sharma K, Jin Y, Guo J, Ziyadeh FN (1996) Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530
94. 1 enhances glomerular collagen synthesis in diabetic-rats. Diabetes 42:1673-1677
95. Ziyadeh FN, Sharma K, Ericksen M, Wolf G (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542
96. Kreisberg JI, Radnik RA, Ayo SH, Garoni J, Saikumar P (1994) High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int 46:105-112
97. Shankland SJ, Scholey JW (1995) Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 47:782-788
98. Messina JL, Standaert ML, Ishizuka T, Weinstock RS, Farese RV (1992) Role of protein kinase C in insulin's regulation of c-fox transcription. J Biol Chem 267:9223-9228
99. 1 isozyme autophosphorylation sites. Proc Natl Acad Sci USA 90:6130-6134
100. Franza BR Jr, Rauscher III FJ, Josephs SF, Curran T (1988) The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239:1150-1153
101. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M (1988) The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54:541-552
102. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB (1990) Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10:1492-1497
103. Dean DC, McQuillian JJ, Weintraub S (1990) Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J Biol Chem 265:3522-3527
104. Okano R, Mita T, Matsui T (1992) Characterization of a novel promoter structure and its transcriptional regulation of the murine laminin B1 gene. Biochim Biophys Acta 1132:49-57
105. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C (1987) Increased Vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Diabetes 36:813-821
106. Oliver JA (1990) Adenylate cyclase and protein kinase C mediate opposite actions on endothelial junctions. J Cell Physiol 145:536-542
107. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J (1991) Diacylglycerol accumulation and micro-vascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31-38
108. Werth DK, Niedel JE, Pastan I (1983) Vinculin, a cytoskeletal substrate of protein kinase C. J Biol Chem 258: 11423-11426
109. 77 and vimentin and enhances albumin permeability across cultured bovine pulmonary artery endothelial cell monolayers. J Cell Physiol 153:62-75)
110. Schliwa M, Nakamura T, Porter KR, Euteneuer U (1984) A tumor promoter induces rapid and coordinated reorganization of actin and vinculin in cultured cells. J Cell Biol 99: 1054-1059
111. Ben-Ze'ev A (1986) Tumor promoter-induced disruption of junctional complexes in cultured epithelial cells is followed by the inhibition of cytokeratin and desmoplakin synthesis. Exp Cell Res 164:335-352
112. Turner CE, Pavalko FM, Burridge K (1989) The role of phosphorylation and limited proteolytic cleavage of talin and vi-nculin in the disruption of focal adhesion integrity. J Biol Chem 264:11938-11944
113. 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 166: 249-255
114. Gamou S, Shimizu N (1994) Calphostin-C stimulates epidermal growth factor receptor phosphorylation and internalization via light-dependent mechanism. J Cell Physiol 158: 151-159
115. Xia P, Feener EP, King GL (1994) Elevated glucose level regulates epidermal growth factor receptor (EGF-R) in aortic smooth muscle cells overexpressing protein kinase C. Diabetes 43 [Suppl 1]:101A
116. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL (1994) Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487
117. Xia P, Aiello LP, Ishii H, Jiang Z, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026
118. +-ATPase. Biochim Biophys Acta 1154:201-222
119. King GL, Shiba T, Oliver J, Inoguchi T, Bursell S-E (1994) Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med 45:179-188
120. Winegrad AI (1987) Does a common mechanism induce the diverse complications of diabetes? Diabetes. 36:396-406
121. MacGregor LC, Matschinsky FM (1986) Altered retinal metabolism in diabetes. II. measurement of sodium-potassium ATPase and total sodium and potassium in individual retinal layers. J Biol Chem 261:4052-4058
122. Greene DA, Lattimer SA (1986) Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve: implications for (Na.K)-ATPase regulation and diabetic complications. Diabetes 35:242-245
123. Schwartzman M, Ferreri NR, Carroll MA, Songu-Mize E, McGiff JC (1985) Renal cytochrome P450-related arachidonate metabolite inhibits (Na-K)ATPase. Nature (Lond) 314: 620-622
124. 2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. J Clin Invest 87: 1992-1998
125. +-ATPaSe. II. Role of eicosanoids. J Clin Invest 91:409-415
126. 2. J Clin Invest 96: 733-740
127. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald III JH, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM (1996) (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3, 4-h][1, 4, 13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase Cb. J Med Chem 39:2664-2671
128. Boscoboinik D, Szewczyk A, Hensey C, Azzi A (1991) Inhibition of cell proliferation by α-tocopherol. J Biol Chem 266:6188-6194
129. Kunisaki M, Bursell S-E, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL (1995) Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 269:E239-E246
130. Lee I-K, Koya D, Ishii H, King GL (1996) Vitamin E (vit E) prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes 45 [Suppl 2]:64A
131. Koya D, Lee I-K, Ishii H, Kanoh H, King GL (1997) Prevention of glomerular dysfunctions in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol (in press)
132. Koya D, Jirousek MR, Ishii H, King GL (1996) Characterization of the role of PKC β in the regulation of extracellular matrix abnormalities in diabetic rats. J Am Soc Nephrol 7:1874